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ABSTRACT 18 
The global emergence of plasmid-mediated colistin resistance genes mcr-1 and mcr-3 has 19 
threatened the role of the “last resort” drug colistin in the defense against infections caused 20 
by multidrug-resistant Gram-negative bacteria. However, functional differences between 21 
these two genes in mediating colistin resistance remains poorly understood. Protein sequence 22 
alignment of MCR-3 and MCR-1 was therefore conducted in Clustal Omega to identify 23 
sequence divergence. The molecular recognition of lipid A head group 24 
phosphatidylethanolamine and MCR-3 enzyme was studied by homology modeling and 25 
molecular docking, with the catalytic mechanism of MCR-3 also being explored. Thr277 in 26 
MCR-3 was validated as the key amino acid residue responsible for the catalytic reaction 27 
using site-directed mutagenesis and was shown to act as a nucleophile. Lipid A modification 28 
induced by the MCR-3 and MCR-1 enzymes was confirmed by electrospray ionization 29 
time-of-flight mass spectrometry. Far-UV circular dichroism spectra of the MCR-3 and 30 
MCR-1 enzymes suggested that MCR-3 was more thermostable than MCR-1, with a melting 31 
temperature of 66.19°C compared with 61.14°C for MCR-1. These data provided molecular 32 
insight into the functional differences between mcr-3 and mcr-1 in conferring colistin 33 
resistance.  34 
Keywords: mcr-3, mcr-1, colistin resistance, homology modeling, phosphatidylethanolamine  35 
 o
n
 August 9, 2018 by Cardiff Univ
http://aac.asm
.org/
D
ow
nloaded from
 
3 
 
INTRODUCTION 36 
The emergence of multidrug-resistant Gram-negative pathogenic bacteria represents one 37 
of the greatest global public health threats to date (1). Colistin is considered the last line of 38 
defense against many of these clinical multidrug-resistant microorganisms (2, 3). The 39 
antibacterial activity of colistin occurs as a result of an electrostatic interaction between the 40 
α,Ȗ-diaminobutyric acid residue of the positively-charged colistin and the phosphate groups 41 
of the negatively-charged lipid A membrane. This destabilizes the lipopolysaccharide, 42 
consequently increasing the permeability of the bacterial membrane. The colistin molecule 43 
can then insert itself into the bacterial cell (2, 4). Modification of lipid A at the 1′ and 4′ head 44 
group positions with phosphoethanolamine (PEA) or 4-amino-arabinose masks the 45 
negatively-charged phosphate groups on the bacterial surface, thereby preventing the 46 
interaction with cationic antimicrobial peptides such as colistin and polymyxin B (5). 47 
Plasmid-mediated mobilized colistin resistance (MCR) enzymes, encoded by mcr-1–5 (6-10), 48 
are members of the PEA transferase family of proteins that decorate the lipid A head groups 49 
of lipopolysaccharide with PEA, thereby conferring colistin resistance. 50 
Recently, we described a new transferable plasmid-borne colistin resistance gene, mcr-3, 51 
in an Escherichia coli isolate from pig feces (7). Subsequent epidemiological studies have 52 
shown that, similar to mcr-1, mcr-3 is widespread amongst various species of 53 
Enterobacteriaceae and Aeromonas (11-14). Considering the spread and prevalence of these 54 
two genes and their potential harm with regard to drug-resistant bacterial infections (15-17), 55 
this study aimed to provide molecular insights into the functional differences between mcr-3 56 
and mcr-1. Furthermore, the molecular mechanism underlying substrate binding by mcr-3 57 
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remains to be elucidated, and there is virtually no research deciphering its role in mediating 58 
colistin resistance. To address these issues, we carried out homology modeling and examined 59 
the molecular docking of MCR-3 with the substrate, L-α-phosphatidylethanolamine 60 
(L-αPEA), from E. coli. Identifying the catalytic mechanism and possible binding sites would 61 
aid in subsequent characterization of their biological characteristics. We also expressed and 62 
purified MCR-1 and MCR-3 and determined the thermal stability and secondary structure of 63 
these two lipid A PEA transferases. These functional comparisons showed that MCR-3 was 64 
more thermostable than MCR-1. 65 
 66 
MATERIALS AND METHODS 67 
Strains and plasmid construction 68 
mcr-3 was cloned from the genomic DNA of E. coli plasmid pWJ1 by PCR using 69 
forward (5ʹ-GGGAATTCCATATGATGCCTTCCCTTATAAAAAT-γʹ) and reverse 70 
(5ʹ-AAGGAAAAAAGCGGCCGCTTATTGAACATTACGACATTGAC-γʹ) primers 71 
incorporating NdeI and NotI restriction sites at the N- and C-termini of the coding region, 72 
respectively. The resulting PCR products were digested with the corresponding restriction 73 
enzymes and ligated into expression vector pET28a, generating pET28a-mcr-3. mcr-1 was 74 
then PCR-amplified from E. coli strain SHP45 genomic DNA using forward 75 
(5ʹ-CATGCCATGGTGATGATGCAGCATACTTCTGTGTGGTACCGACG-γʹ) and reverse 76 
(5ʹ-CAAAGACCGCACCGCATTCATCCGCCTCGAGCGG-γʹ) primers and cloned into 77 
plasmid pET28a to generate a high-copy expression vector with an N-terminal hexa-histidine 78 
tag (pET28a-mcr-1). The resulting recombinant MCR-3 and MCR-1 proteins contained a 79 
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tobacco etch virus protease cleavage site followed by a 6×His tag at the N terminus. The 80 
calculated molecular masses of both the recombinant and cleaved monomeric MCR-3 and 81 
MCR-1 proteins were ~60 kDa.  82 
Expression and purification of full-length MCR-3 and MCR-1 83 
For overexpression analyses, pET28a-mcr-3 and pET28a-mcr-1 were individually 84 
transformed into E. coli BL21 (DE3) pLysS chemically-competent cells. The transformants 85 
were then cultured in Luria Bertani (LB) medium supplemented with 50 µg/ml kanamycin at 86 
37 °C with shaking for 3–4 h, or to an optical density at 600 nm (OD600) of 0.5–0.6. Protein 87 
expression was induced by the addition of 0.4 mM isopropyl-ȕ-D-thiogalactopyranoside and 88 
incubation at 18 °C for a further 20 h. Cells were harvested by centrifugation at 10,000 × g 89 
for 10 min at 4 °C and then re-suspended in lysis buffer (50 mM sodium phosphate buffer, pH 90 
8.0, containing 300 mM sodium chloride and 10 mM imidazole). Cell debris was removed by 91 
centrifugation at 12,000 × g for 20 min at 4 °C, and membranes were collected by further 92 
ultracentrifugation of the supernatant at 100,000 × g for 1 h at 4 °C using an ultracentrifuge 93 
(Optima XE-100; Beckman Coulter, Brea, CA, USA). The resulting pellet was homogenized 94 
in phosphate-buffered saline containing 1% n-dodecyl-ȕ-D-maltoside (DDM) and solubilized 95 
for 2 h at 4 °C on a rotational shaker at 50 rpm. 96 
To purify the full-length MCR-1 and MCR-3, protein-containing supernatant was applied 97 
to a Ni-NTA Superflow resin column (Qiagen, Hilden, Germany) equilibrated with binding 98 
buffer (50 mM sodium phosphate, pH 7.5, 300 mM NaCl, 10 mM imidazole). The unbound 99 
protein was washed from the column using washing buffer (50 mM sodium phosphate, pH 100 
7.5, 300 mM NaCl, 20 mM imidazole), and the bound protein was eluted from the column 101 
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using elution buffer (50 mM sodium phosphate, pH 7.5, 300 mM NaCl, 200 mM imidazole, 102 
0.05% (w/v) DDM). The eluent fractions were pooled and concentrated using a Vivaspin 20 103 
centrifugal concentrator (MWCO 10 K; Sartorius, Göttingen, Germany) to a final 104 
concentration of 5–10 mg/ml, as determined by the absorbance at 280 nm using a NanoDrop 105 
2000c spectrophotometer. 106 
Isolation and mass spectrometry of lipid A 107 
The construction of E. coli strains W3110 (pUC19), W3110 (pUC19-mcr-3), and W3110 108 
(pUC19-mcr-1) was described in our previous research (6, 7). Bacterial cultures (200 ml) 109 
were incubated overnight in LB broth at 37 °C, and then cells were harvested by 110 
centrifugation at 10,000 × g for 10 min. Lipid A was isolated by mild acidic hydrolysis 111 
according to the method described previously by Hankins et al. (18). Lipid A was analyzed 112 
using electrospray ionization quadrupole time-of-flight mass spectrometry (ESI-TOF/MS) 113 
(Waters Synapt HR-MS, Milford, USA) in the negative-ion mode. The ESI-TOF/MS settings 114 
were as follows: capillary voltage, 3.0 kV; sampling cone voltage, 30 V; source temperature, 115 
100 °C; desolvation temperature, 500 °C; and desolvation gas (N2), 600 l/h. 116 
Circular dichroism (CD) spectroscopy  117 
The far-UV spectra of MCR-1 and MCR-3 were measured at 20 °C on a CD 118 
spectrophotometer (Jasco J-810, Tokyo, Japan) using a 1-mm path-length quartz cuvette. The 119 
protein sample was diluted to a concentration of 0.2 mg/ml in 5 mM sodium phosphate (pH 120 
7.0). CD data were collected every 1 nm using a 1-nm bandwidth in the 185–260-nm 121 
wavelength region using an integration time of 1 s per step. Temperature-dependent CD 122 
analysis was carried out at 220 nm with a temperature range of 10–90 °C and a rate of 123 
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1 °C/min to determine the melting temperature (Tm). The resulting spectra represented the 124 
average of three accumulations and were buffer-baseline corrected with the signal-to-noise 125 
ratio improved using the Savitzky-Golay method with a minimum convolution width of 5 126 
data points. Analysis was conducted using Spectra Analysis software (version 1.53.07 for 127 
Windows 95/NT; JASCO Corp., Tokyo, Japan). 128 
Molecular docking 129 
To provide an overview of full-length MCR-3, structural modeling was performed using 130 
two approaches: the SWISS-MODEL workspace and the Modweb server (19, 20). Sequence 131 
alignment of MCR-1, MCR-3, and EptA was conducted using Clustal Omega 132 
(http://www.ebi.ac.uk/Tools/msa/clustalo/). The crystal structure of EptA (PDB ID: 5FGN) 133 
was used for modeling by comparing the E-value and the structure total score. The EptA 134 
structure was embedded into L-αPEA from E. coli using the Swiss-Model automated 135 
homology-modeling server (https://swissmodel.expasy.org/). PROCHECK and ERRAT were 136 
used to evaluate the optimized model protein structure. A Ramachandran plot was used to 137 
illustrate the degree of rotation of the bonds between the α-carbon atoms and the carbonyl 138 
carbon atoms of the peptide bond in a peptide or peptide structure of a protein. The degree of 139 
rotation of the bond between the α-carbon atom and the nitrogen atom was mainly used to 140 
indicate permitted and impermissible conformations of amino acid residues. The structure of 141 
the protein after modeling was studied to further discuss the rationality of the model and 142 
analyze the catalytic structure of MCR-3.  143 
The interaction between the ligand and the MCR-3 protein structure, determined by 144 
homology modeling, was investigated using AutoDock Tools 1.5.6, which generated the 145 
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pdbqt files used for molecular docking analysis. Molecular docking was completed using the 146 
MolDesigner molecular simulation platform of AutoDock Vina (21). If the molecular docking 147 
results produced unreasonable atomic contacts in the spatial structure, energy-optimized 148 
methods were used to release these forces to stabilize the structure. 149 
Construction of mcr-3 site-directed mutants 150 
To test the role of Thr277 in MCR-3, two different substitution-inducing mutations 151 
(Thr277Ala and Thr277Ser) were introduced into mcr-3 in pUC19-mcr-3 using a 152 
QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies, Santa Clara, 153 
CA, USA) as per the manufacturer’s protocol using primers Thrβ77Ala-F 154 
(5ʹ-TCGTGTGGGACTGCAGCCGCTGTATCCGTCCCC-γʹ) and Thr277Ala-R 155 
(5ʹ-GGGGACGGATACAGCGGCTGCAGTCCCACACGA-γʹ), and Thr277Ser-F 156 
(5ʹ-TCGTGTGGGACTGCAAGCGCTGTATCCGTCCCC-γʹ) and Thr277Ser-R 157 
(5ʹ-GGGGACGGATACAGCGCTTGCAGTCCCACACGA-γʹ), respectively. These primers 158 
introduced an ACC (coding for threonine) to GCC (coding for alanine) or AGC (coding for 159 
serine) mutation at residue 277 of MCR-3. Recombinant plasmids containing wild-type mcr-3 160 
or each of the two mutations (Thr277Ala and Thr277Ser) were then transformed into host E. 161 
coli strain DH5α. Sequencing of the complete mcr-3 genes from each of the transformants 162 
was conducted to ensure no extraneous mutations occurred. Minimum inhibitory 163 
concentrations (MICs) of colistin and polymyxin for E. coli DH5α, DH5α (pUC19), DH5α 164 
(pUC19-mcr-3), and each of the site-directed mutants were measured by the broth 165 
microdilution method according to the Clinical and Laboratory Standards Institute guidelines 166 
(22). 167 
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 168 
RESULTS AND DISCUSSION 169 
Lipid A modification mediated by mcr-3 and mcr-1 confirmed by ESI-TOF/MS 170 
mcr-3 and mcr-1 encode PEA transferases that mediate colistin resistance in a variety of 171 
bacterial species, including E. coli, Aeromonas veronii, Salmonella enterica serovar 172 
Typhimurium, Klebsiella pneumoniae, and Citrobacter freundii (12-14). In this study, lipid A 173 
was extracted from recombinant E. coli strains W3110 (pUC19-mcr-3), E. coli W3110 174 
(pUC19-mcr-1), and E. coli W3110 (pUC19) and the lipid spectra was analyzed by 175 
ESI-TOF/MS. ESI-MS/MS spectra showed that lipid A from E. coli W3110 (pUC19) had a 176 
prominent peak at m/z 1797.10 (Fig. 1A). Upon the addition of a PEA molecule (123 Da) to 177 
the bis-phosphorylated hexa-acylated lipid A in both E. coli W3110 (pUC19-mcr-1) and 178 
W3110 (pUC19-mcr-3), the peak shifted to m/z 1920 (i.e., 1797 + 123) (Fig. 1B, C). Previous 179 
research has shown that MCR-1 can transfer PEA from phosphatidylethanolamine to the 180 
negatively-charged phosphate groups of lipid A, resulting in decreased affinity for colistin (23, 181 
24). The proposed lipid A modification catalyzed by MCR-3 is shown in Fig. 1D. Thus, we 182 
confirmed that MCR-3, like MCR-1, could modify lipid A on the bacterial cell membrane, 183 
thereby mediating colistin resistance. 184 
Comparison of the models of full-length MCR-3 and MCR-1 185 
Four proteins, EptA (PDB:5FGN), LptA (PDB:4KAY and 4KAV), and MCR-1 186 
(PDB:5K4P), were aligned to select a template for homology modeling. In general, protein 187 
crystals with higher total scores or E-values less than 1e−5 can be considered for use as 188 
templates. Both the SWISS-MODEL workspace and the Modweb server automatically 189 
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selected full-length EptA as the template for homology modeling and returned similar 190 
modeling results (Table 1 and Fig. 2). Template 5FGN had the highest score with the target 191 
sequence, with a sequence identity of 39%. Templates 4KAY and 4KAV reached 44% 192 
sequence identity but the sequence coverage was only 60% (Table 1), indicating that they 193 
were missing part of the structure and were not suitable as templates for building a complete 194 
protein model. 5K4P only showed 35% sequence identity with MCR-3. 195 
The structure of MCR-3 was composed of two folded domains: an N-terminal 196 
transmembrane (TM) domain and a C-terminal catalytic domain. The TM domain consisted 197 
of five membrane-spanning α-helices (residues 1–212) connected to the catalytic domain via 198 
a bridging helix (Fig. 3). There were multiple lysine and histidine residues on the membrane 199 
surface, and these basic amino acids could improve the stability of MCR-3 on the membrane 200 
to a certain extent. The soluble cytoplasmic domain had a similar structure to the hydrolase 201 
active site (5). The Zn2+ ions bound to the active site and formed tetrahedral coordination 202 
structures with Glu238, Thr277, Asp450, and His451, with distances of 1.9, 2.2, 2.0, and 1.9 203 
Å, respectively. Thr277 was the key amino acid responsible for the catalytic reaction, acting 204 
as a nucleophile. In addition, disulfide bonds formed by five pairs of cysteines were 205 
distributed in this region, which stabilized the structure of the region as a whole. Furthermore, 206 
conserved residue Thr285 in the MCR-1 catalytic domain structure is believed to act as the 207 
acceptor for the PEA group during the transfer reaction (25-27). MCR-1 transfers PEA to 208 
lipid A, which is located in the nearby pocket consisting of Thr283, Ser284, Tyr287, Pro481, 209 
and Asn482 (28). It was demonstrated that a threonine  residue (Thr285 for MCR-1 and 210 
Thr277 for MCR-3) in the catalytic domain played an important role in mediating colistin 211 
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resistance. The rationality of the MCR-3 protein homology modeling and the structural 212 
integrity of the catalytic active center proved the reliability of the structure and could be used 213 
for subsequent molecular docking analyses to explore the catalytic mechanism of MCR-3. 214 
Catalytic reaction mechanism of MCR-3 deciphered by molecular docking 215 
Prior to the catalytic transfer of PEA by MCR-3, the side-chain hydroxyls of the 216 
catalytically-active Thr277 lose their hydrogen protons, forming oxyanions by nucleophilic 217 
attack. In the MCR-3 model, the amino acid residues Glu111, His380, and His463 could 218 
receive the hydrogen proton in the vicinity of the catalytic center. The distances between the 219 
oxygen of Thr277 and the three residues were 5.3, 5.4, and 5.1 Å, respectively. It would be 220 
difficult to directly transfer the proton from these spatial distances. However, there was a 221 
water molecule between these three amino acids, which was not present in the catalytic center 222 
of the general template crystal structure of EptA. The hydrogen protons of Thr277 are 223 
therefore likely to be transferred by the water molecule to the three residues. The results of 224 
molecular docking analysis showed that PEA could bind to the catalytically-active cavity of 225 
MCR-γ, with a binding energy of −7.1 kcal/mol. The main driving power of PEA binding 226 
was the “head” hydrogen and the “tail” hydrophobicity (Fig. 4). The PEA moiety at the head 227 
of L-αPEA formed a hydrogen bond network with Glu111, Thr277, Ala278, His451, and 228 
His463. These hydrogen bonds would stabilize the PEA head in the catalytic center of the 229 
MCR-3 enzyme, which would be favorable for the subsequent catalytic reaction. The alkyl 230 
chain at the terminus of L-αPEA extended into the transmembrane region of the MCR-3 231 
protein and formed strong hydrophobic bonds with the Ile84, Thr88, Val94, Asn103, Ile104, 232 
Ala112, Tyr115, Leu116, Ile120, and Leu462 residues. This hydrophobic interaction would 233 
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enhance the stable binding of the PEA substrate to the active cavity of the MCR-3 enzyme.  234 
We further analyzed the binding conformations and found that the distance between the 235 
O1 of the L-α-PEA molecule and Zn2+ in the catalytic center was 2.7 Å, while the distance 236 
between the P atom of the phosphoric acid group and the O atom of the Thr277 hydroxyl was 237 
3.1 Å. This finding demonstrated that the two pairs of atoms might be separated by the 238 
electrostatic interactions of the O1-Zn and P-O covalent bonds, respectively. It was also 239 
noteworthy that the O2 of the terminal alkyl side chain in L-αPEA formed a hydrogen bond 240 
with His463 at a distance of 2.2 Å, indicating that hydrogen protons on His463 might be 241 
transferred to the O2 of L-αPEA. The P-O2 bond then broke to form a product. We 242 
concluded that the hydrogen proton of Thr277 was likely to be transferred to the His463 243 
residue via a water molecule. The protonated His463 could then provide hydrogen protons to 244 
the alkyl chains at the ends of L-αPEA to complete the entire catalysis reaction.  245 
Next, we speculated on the possible mechanism of the MCR-3-catalyzed reaction (Fig. 5). 246 
The reaction was divided into two main steps: (1) the hydrogen protons on the 247 
catalytically-active Thr277 side chain hydroxyls in MCR-3 were transferred to the nitrogen of 248 
the His466 residue side chains via water molecules. Thr277 was further activated to become a 249 
nucleophilic attacking group, and the protonated His463 residue was subsequently involved 250 
in the reaction as a hydrogen proton donor. At the same time, the carboxylate of Glu238 251 
would attract the carboxyl hydrogen proton of Asp321 to Glu238, leaving the catalytic center 252 
electrically neutral. (2) During L-αPEA binding to the catalytically-active site, the O1 of the 253 
phosphate group coordinates with Zn to form a coordinate covalent bond. P forms a covalent 254 
bond with the hydroxyl oxygen of Thr277, and the covalently-linked bonds between the O2 255 
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in the terminal alkyl side chain and P were broken, forming the Thr-PEA complexes. The 256 
Thr-PEA complex is a positively-charged group, which would result in a decrease in the 257 
negative charge of the bacterial outer membrane, reducing the absorbance capacity of the 258 
bacterium for positively-charged colistin, which in turn leads to bacterial resistance to 259 
colistin.  260 
Mutation of Thr277 decreases MCR-3 function 261 
As Thr277 was considered to be the key amino acid responsible for the catalytic reaction, 262 
mutation of this amino acid would be expected to decrease the functional abilities of MCR-3. 263 
To test this hypothesis, we constructed two strains carrying plasmid pUC19-mcr-3 containing 264 
mutations within MCR-3 (Thr277Ala and Thr277Ser). We then measured the MICs of 265 
colistin and polymyxin for these strains in comparison with the wild-type. The MIC of 266 
colistin for the strain containing pUC19-mcr-3 was 4.0 µg/ml, compared with 0.5 µg/ml for 267 
the control strain containing empty plasmid (pUC19). The strain containing a Thr277Ala 268 
substitution in MCR-3 had a colistin MIC similar to that of the control (0.5–1 µg/ml, Table 2), 269 
while the Thr277Ser mutation resulted in a 4-fold decrease in the MICs of colistin and 270 
polymyxin compared with the E. coli DH5α (pUC19-mcr-3) strain (Table 2). Taken together, 271 
site-directed mutagenesis verified the importance of the Thr277 residue to the catalytic 272 
activity of lipid A. 273 
MCR-3 shows greater thermostability than MCR-1 274 
In the absence of high-resolution structures, CD is the method of choice for providing 275 
secondary structural information for proteins in solution (29). To explore the resistance 276 
mechanism of the novel MCR-3 protein and compare its structure and function with MCR-1, 277 
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we expressed and purified the full-length MCR-3 protein. Characterization of the secondary 278 
structures of MCR-1 and MCR-3 was then achieved using CD spectra. The normalized CD 279 
spectra of MCR-1 and MCR-3 from 185–260 nm are shown in Fig. 6A. MCR-3 and MCR-1 280 
were well-folded, structured proteins and presented similar structural properties with regard 281 
to α-helical and ȕ-sheet content from the deconvolution. We also compared the thermal 282 
stability of MCR-3 and MCR-1 using temperature-dependent CD. As a result, melting 283 
temperatures of approximately 66.19 °C and 61.14 °C were obtained for MCR-3 and MCR-1, 284 
respectively. The CD results showed clear differences in the thermal stabilities of the two 285 
proteins (Fig. 6B) and revealed that MCR-3 was more thermostable than MCR-1 (p < 0.05). 286 
The differences in stability with respect to thermal denaturation, with >5 °C difference in 287 
melting temperature, implied that the catalytic properties of the two proteins in mediating 288 
bacterial resistance might differ. Therefore, further investigation should focus on the 289 
association of thermodynamic stability and enzymatic function of different MCR proteins. 290 
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 393 
Figure Legends 394 
FIG. 1 ESI-QTOF/MS analysis showing the PEA modification of bacterial lipid A 395 
mediated by MCR-3 and MCR-1. (A) ESI-QTOF/MS spectrum of the negative ion of lipid 396 
A extracted from the recombinant control strain E. coli W3110 (pUC19). Lipid A had a 397 
prominent peak at m/z 1797.10 but no peak at m/z 1920, indicating no PEA modification. (B) 398 
ESI-QTOF/MS spectrum of the negative ion of lipid A extracted from the recombinant 399 
positive control strain E. coli W3110 (pUC19-mcr-1). A PEA molecule (123 Da) was added 400 
to the bisphosphorylated hexa-acylated lipid A (m/z = 1920; i.e., 1797 + 123). (C) 401 
ESI-QTOF/MS spectrum of lipid A extracted from the recombinant strain E. coli W3110 402 
(pUC19-mcr-3). The peak observed at m/z 1920 was consistent with the addition of a single 403 
PEA group (123 Da) to ions represented by the prominent peak at m/z 1797.2, corresponding 404 
to dephosphorylated lipid A. (D) Reaction catalyzed by MCR-3. 405 
FIG. 2 Multiple sequence alignment of MCR-3, MCR-1, and EptA conducted using 406 
Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/). 407 
FIG. 3 Three-dimensional structure of MCR-3 generated by homology modeling. The 408 
protein was shown as a gray strip model. The catalytic residues were shown as a stick model, 409 
and Zn2+ ions were shown by a gray sphere. The numbers in red indicated the distance 410 
between coordination bonds (Å). 411 
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FIG. 4 Schematic showing the interaction between L-αPEA and the amino acids around 412 
the active site of MCR-3. (A) Hydrophobic residues were indicated by the green solid line 413 
and green residue labels, while the black dashed line represented the hydrogen bond. (B) 414 
Three-dimensional model of the binding between L-αPEA and the MCR-3 active site. The 415 
protein was shown in gray, with interacting residues shown as a green stick model, L-αPEA 416 
as a yellow stick model, and zinc ions in gray spheres, with black dotted lines indicating the 417 
interaction and distance between the L-αPEA and MCR-3 molecules. 418 
FIG. 5 Proposed reaction mechanism of L-αPEA catalyzed by MCR-3. 419 
FIG. 6 Secondary structure characterization of MCR-1 and MCR-3 by CD analysis. (A) 420 
Normalized CD spectra of MCR-1 and MCR-3. Data were obtained at 20 °C using 10 mM 421 
phosphate buffer, with a protein concentration of ~2.5 µM. (B) Thermal stability melting 422 
curves. Melting temperatures of MCR-1 and MCR-3 as determined by CD. MCR-1: 61.14 °C; 423 
MCR-3: 66.19 °C.424 
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FIG. 1 ESI-QTOF/MS analysis showing the PEA modification of bacterial lipid A 430 
mediated by MCR-3 and MCR-1. (A) ESI-QTOF/MS spectrum of the negative ion 431 
of lipid A extracted from the recombinant control strain E. coli W3110 (pUC19). 432 
Lipid A had a prominent peak at m/z 1797.10 but no peak at m/z 1920, indicating no 433 
PEA modification. (B) ESI-QTOF/MS spectrum of the negative ion of lipid A 434 
extracted from the recombinant positive control strain E. coli W3110 (pUC19-mcr-1). 435 
A PEA molecule (123 Da) was added to the bisphosphorylated hexa-acylated lipid A 436 
(m/z = 1920; i.e., 1797 + 123). (C) ESI-QTOF/MS spectrum of lipid A extracted from 437 
the recombinant strain E. coli W3110 (pUC19-mcr-3). The peak observed at m/z 1920 438 
was consistent with the addition of a single PEA group (123 Da) to ions represented 439 
by the prominent peak at m/z 1797.2, corresponding to dephosphorylated lipid A. (D) 440 
Reaction catalyzed by MCR-3. 441  on
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 442 
FIG. 2 Multiple sequence alignment of MCR-3, MCR-1, and EptA conducted 443 
using Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/). 444 
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FIG. 3 445 
 446 
FIG. 3 Three-dimensional structure of MCR-3 generated by homology modeling. 447 
The protein was shown as a gray strip model. The catalytic residues were shown as a 448 
stick model, and Zn2+ ions were shown by a gray sphere. The numbers in red 449 
indicated the distance between coordination bonds (Å). 450 
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FIG. 4 451 
 452 
FIG. 4 Schematic showing the interaction between L-αPEA and the amino acids 453 
around the active site of MCR-3. (A) Hydrophobic residues were indicated by the 454 
green solid line and green residue labels, while the black dashed line represented the 455 
hydrogen bond. (B) Three-dimensional model of the binding between L-αPEA and the 456 
MCR-3 active site. The protein was shown in gray, with interacting residues shown as 457 
a green stick model, L-αPEA as a yellow stick model, and zinc ions in gray spheres, 458 
with black dotted lines indicating the interaction and distance between the L-αPEA 459 
and MCR-3 molecules. 460 
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FIG. 5  461 
462 
FIG. 5 Proposed reaction mechanism of L-αPEA catalyzed by MCR-3. 463 
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FIG. 6 464 
 465 
FIG. 6 Secondary structure characterization of MCR-1 and MCR-3 by CD analysis. (A) 466 
Normalized CD spectra of MCR-1 and MCR-3. Data were obtained at 20 °C using 10 mM 467 
phosphate buffer, with a protein concentration of ~2.5 µM. (B) Thermal stability melting 468 
curves. Melting temperatures of MCR-1 and MCR-3 as determined by CD. MCR-1: 61.14 °C; 469 
MCR-3: 66.19 °C.470 
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Tables 471 
Table 1 Multiple sequence alignment of the selected homology templates. 472 
 
Template Total score E-value Identity Query cover Resolution/ Å 
MCR-3 5FGN 408 7e-137 39% 98% 2.75 
 4KAY 310 2e-101 44% 60% 1.78 
 4KAV 301 5e-98 44% 60% 1.43 
 5K4P 305 6e-97 35% 70% 1.32 
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Table 2 MIC values for colistin and polymyxin against E. coli strain DH5α carrying the 473 
wild-type mcr-3 gene or either of the two mutation variants (Thr277Ala and Thr277Ser). 474 
E. coli DH5α Strains Colistin (µg/ml) Polymyxin (µg/ml) 
DH5α 0.5 0.5 
pUC19 0.5 0.5 
pUC19-mcr-3 4 4 
pUC19-mcr-3 (Thr277Ala)  0.5 0.5 
pUC19-mcr-3 (Thr277Ser) 1 1 
 475 
 476 
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